Publication: 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
Issued Date
2021-01-01
Resource Type
ISSN
17583764
17583756
17583756
Other identifier(s)
2-s2.0-85109820982
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
European Cardiology Review. Vol.16, (2021)
Suggested Citation
Jack Wei Chieh Tan, Derek P. Chew, David Brieger, John Eikelboom, Gilles Montalescot, Junya Ako, Byeong Keuk Kim, David K.L. Quek, Sarah J. Aitken, Clara K. Chow, Sok Chour, Hung Fat Tse, Upendra Kaul, Isman Firdaus, Takashi Kubo, Boon Wah Liew, Tze Tec Chong, Kenny Y.K. Sin, Hung I. Yeh, Wacin Buddhari, Narathip Chunhamaneewat, Faisal Hasan, Keith A.A. Fox, Quang Ngoc Nguyen, Sidney T.H. Lo 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome. European Cardiology Review. Vol.16, (2021). doi:10.15420/ECR.2020.45 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/78690
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
Author(s)
Jack Wei Chieh Tan
Derek P. Chew
David Brieger
John Eikelboom
Gilles Montalescot
Junya Ako
Byeong Keuk Kim
David K.L. Quek
Sarah J. Aitken
Clara K. Chow
Sok Chour
Hung Fat Tse
Upendra Kaul
Isman Firdaus
Takashi Kubo
Boon Wah Liew
Tze Tec Chong
Kenny Y.K. Sin
Hung I. Yeh
Wacin Buddhari
Narathip Chunhamaneewat
Faisal Hasan
Keith A.A. Fox
Quang Ngoc Nguyen
Sidney T.H. Lo
Derek P. Chew
David Brieger
John Eikelboom
Gilles Montalescot
Junya Ako
Byeong Keuk Kim
David K.L. Quek
Sarah J. Aitken
Clara K. Chow
Sok Chour
Hung Fat Tse
Upendra Kaul
Isman Firdaus
Takashi Kubo
Boon Wah Liew
Tze Tec Chong
Kenny Y.K. Sin
Hung I. Yeh
Wacin Buddhari
Narathip Chunhamaneewat
Faisal Hasan
Keith A.A. Fox
Quang Ngoc Nguyen
Sidney T.H. Lo
Other Contributor(s)
Siriraj Hospital
The College of Medicine and Public Health
Cleveland Clinic Abu Dhabi
Hopital Calmette
Hanoi Medical University
Universitas Indonesia
Batra Hospital India
McMaster University
Mackay Memorial Hospital Taiwan
The University of Edinburgh
The University of Sydney
Wakayama Medical University
King Chulalongkorn Memorial Hospital
Singapore General Hospital
Yonsei University
Hôpital Universitaire Pitié Salpêtrière
Changi General Hospital
Pantai Holdings Sdn Bhd
The University of Hong Kong
Kitasato University
Westmead Hospital
National Heart Centre, Singapore
Sorbonne Universite
Liverpool Hospital
ACTION Study Group
Sengkang General Hospital
The College of Medicine and Public Health
Cleveland Clinic Abu Dhabi
Hopital Calmette
Hanoi Medical University
Universitas Indonesia
Batra Hospital India
McMaster University
Mackay Memorial Hospital Taiwan
The University of Edinburgh
The University of Sydney
Wakayama Medical University
King Chulalongkorn Memorial Hospital
Singapore General Hospital
Yonsei University
Hôpital Universitaire Pitié Salpêtrière
Changi General Hospital
Pantai Holdings Sdn Bhd
The University of Hong Kong
Kitasato University
Westmead Hospital
National Heart Centre, Singapore
Sorbonne Universite
Liverpool Hospital
ACTION Study Group
Sengkang General Hospital
Abstract
The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy.
